WO1998013692A1 - Microorganism separation system - Google Patents
Microorganism separation system Download PDFInfo
- Publication number
- WO1998013692A1 WO1998013692A1 PCT/GB1997/002583 GB9702583W WO9813692A1 WO 1998013692 A1 WO1998013692 A1 WO 1998013692A1 GB 9702583 W GB9702583 W GB 9702583W WO 9813692 A1 WO9813692 A1 WO 9813692A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- microorganism
- coli
- binding
- antibody
- flask
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/10—Enterobacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- G01N2333/255—Salmonella (G)
Definitions
- the present invention relates to a method for the separation, concentration and detection of microorganisms, in particular pathogenic microorganisms such as Salmonella which may be present in low levels in substrates such as foodstuffs, and to kits for carrying out the method.
- microorganisms such as bacteria
- substrates such as consumer goods like food, medicaments or cosmetic preparations; or samples such as clinical samples, or samples collected for public health testing purposes
- samples such as clinical samples, or samples collected for public health testing purposes
- Classical culture techniques require first a pre-enrichment step in which the substrate is mixed with a non-selective growth medium under culture conditions for a period of up to 24 hours during which time any damaged but still viable bacteria may repair. During this period however, all microorganisms, whether pathogenic or not, will multiply and may provide a high level of background "noise" which can hinder detection of a target species.
- a selective growth amplification technique in which the broth from the pre-enrichment step is mixed with a selective growth medium which favours the target organism under culture conditions for a period of up to 48 hours. After this period, the mixture is plated onto selective diagnostic agar medium, in order to see if any potentially target colonies grow. If potential colonies can be identified after a suitable period of time, confirmation of the identity of the colony for example using biochemical identification techniques and ultimately serology, must be carried out.
- EP-A-0489920 describes a process in which antibodies are used to capture bacteria which are separated and subsequently cultured. Separation of target cells from a mixed population using magnetic beads of microspheres is also known, for example from US Patent No. 4,230,685, EP-A-605003 and P.D. Patel (1 94) Microbiological applications of Immunomagnetic techniques in "Rapid Analysis Techniques in Food Microbiology", Ed P.D. Patel, Blackie Academic & Professional. Glasgow, pp 104-131. Magnetic beads may be coated with antibodies which are specific for particular cell. When beads are added to a sample, any target cell present will be bound to the surface of the beads. The beads can then be removed from the remainder of the sample using magnetic separation. After separation, the cells are then cultured to allow them to reach measurable levels.
- US Patent No. 4,933,410 discloses a method for modifying a polystyrene substrate so that it allows for the covalent linking of a macromolecule such as a specific binding member. The substrate may then be used in diagnosis and therapy for separating cells from blood or other physiological fluids or dispersed tissue.
- US Patent No. 5,389,521 describes a technique whereby bacteria from clinical samples are cultured in the presence of a solid carrier in such a way that bacteria bind to the carrier and cause agglutination of the carrier which may be detected. This technique is applicable only to low volume samples and can be used only to detect particular bacteria which bind to particular carbohydrate compounds.
- the applicants have derived a novel strategy for the real-time separation and concentration of viable microorganisms which allows detection and recovery of target microorganisms from the early stages of incubation in primary enrichment broths using a simple and robust system. This will improve the reliability and speed of testing such as pathogen testing.
- the present invention provides a method for separating and concentrating a microorganism in a sample, which method comprises cultu ⁇ ng said sample in a medium in which said microorganism can multiply in the presence of a surface to which is bound a binding member which binds said microorganism, and directly detecting the presence of microorganism on said surface.
- the process of the invention is suitably employed in a pre-enrichment step and/or selective enrichment step in a process for detecting microorganisms, so that pathogen isolation if concomitant with growth, thus reducing the length of time taken for the process.
- the method of the invention is carried out in a container, such as a flask, the surface of which has been modified so that it carries the binding member.
- a membrane which carries the binding member may be placed inside the flask prior to the introduction of the sample.
- Examples of such containers include small scale reagent flasks, for example of from 25-1000 ml volumes, or other commercially available culture-type vessels (e.g. tissue culture flasks and roller bottles), depending upon the volume of the sample for testing.
- the volumes of sample in which the method may be employed may if required be relatively high for sample evaluation, for example from 20-500 ml, suitably for 25 - 225 ml samples.
- microorganisms is detected directly on the surface, for example on the sides of the flask (which are preferably of a transparent material) or the membrane itself. This allows the process to be effected more rapidly and involves fewer processing operations.
- the surface is a substantially planar surface.
- the surface is a hydrophilic affinity surface as this results in the specific agglomeration and growth of target organisms present at the surface, which is conducive to the culture process.
- examples of such surfaces include modified polystyrene surfaces for example as described in US Patent No. 4,933,410.
- Containers comprising flasks of suitable material are sold as "Microcellector flasks" by Applied Immunosciences Inc., Menlo Park California.
- the surface may comprise a regenerated cellulose membrane.
- membranes have been used hitherto for simple ultra filtration purposes or general filtration purposes, they have not previously been used as hydrophilic immunoaffinity support mediums for the immobilisation of specific viable microorganisms as in the method of the present invention.
- Particular membranes which are useful in the method of the invention include those having a pore size which allow proteins to pass through but which are too small to allow passage of the target bacterial species. In general therefore, membranes with pore sizes which do not exceed O. ⁇ microns may be preferred.
- Binding members are suitably specific for the target microorganism. These may include primary monoclonal or polyclonal antibodies as well as binding fragments such as Fab or F(ab')2 fragments thereof, and other binding proteins such as lectins.
- Immobilisation of binding members such as antibodies or binding fragments thereof on the said surface may be carried out in various way. These include (a) direct non-specific adsorption; (b) covalent coupling via a spacer chemical linkage such as a hydrocarbon chain and (c) by first binding an antibody binding protein such as Protein A or Protein G to the surface before application of the binding antibody.
- a protein comprising an antibody binding domain and a surface binding domain such as a cellulose binding domain, is applied to the surface, and the binding antibody applied subsequently.
- the said protein is suitably designed so as to ensure that the antibody against the target microorganism is orientated so as to ensure good binding to the target by way of the F(ab) 2 portion of the antibody and at an effective distance from the membrane surface. Even coverage of the surface is also preferred to avoid “patches" where target organisms may not bind.
- a particularly preferred protein for use in attaching an antibody to a nitrocellulose membrane comprises a cellulose binding domain-Protein A conjugate obtainable from Sigma Chemical Co. under the trade name Cellulose binding domain Protein A fusion protein (CBD-Protein A).
- binding member Once the binding member is fixed to the surface, remaining binding sites are suitably blocked using a blocking agent such as casein, as is understood in the art.
- a blocking agent such as casein, as is understood in the art.
- Detection of the microorganisms can be effected using techniques known in the art.
- a diagnostic or selective detection system is preferable as this will eliminate any non-target organisms which become attached to the surface as a result of non-specific binding.
- the microorganisms may be made visible, for example by applying selective diagnostic growth media such as xylose lysine desoxycholate (XLD) agars which result in the production of visible colonies whose colour depends upon the nature of the organism.
- This media may be applied directly to the surface, for example by applying a thin coat to the surface of the reaction flask where this constitutes the surface, or by placing a porous membrane forming the surface directly onto an agar plate.
- the membrane may be blotted onto the plate as is conventional in the art.
- direct or indirect labels may be applied to the microorganisms using techniques such as ELISA
- the labels are administered by way of a binding element which attaches itself to the microorganisms
- the binding element will be specific for a particular organism and may comprise an antibody or antibody binding fragment
- the label means will be attached to the binding element
- Labels may be able to generate a visible signal directly such as particulate gold or latex labels or che ⁇ uluminescent labels or bioluminescent labels such as the luciferase/lucifenn system Fluorescent labels which become visible when illuminated with light of a particular wavelength such as ultraviolet light, or radioactive labels may also be used
- an enzyme label such as horse radish peroxidase and phosphatase which acts as an indirect label by changing the colour of an applied substrate or the vitamin biotin which can be detected as a result of its reaction with enzyme-linked avidin or streptavidin
- telomeres DNA sequences
- adenylate kinase for example using biolummescence reagents such as the luciferase/lucifenn system
- biolummescence reagents such as the luciferase/lucifenn system
- PCR polymerase chain reaction
- the detection system used is one which requires minimal additional processing or manipulation
- the surface to which the microorganism is bound comp ⁇ ses the surface of a transparent flask
- the use of a visible label or fluorescent label may be preferred
- the simple application of diagnostic growth mediums can produce visible colonies within the flask which can be detected readily
- the surface compnses a membrane contained m a flask it will generally be easier to remove the membrane from the flask before the detection step
- the time required to specifically separate Salmonella may be reduced by further optimisation of the test conditions (e.g. antibody concentration, incubation temperature, use of mixing etc.).
- antibody concentrations of from 0.1 to lOO ⁇ g/ml and temperatures in the range of from 20 to
- this technique has shown significant specific separation of S. enteritidis from a mixed culture containing S. enteritidis and E coli at equal levels (approximately 10 5 cfu/ml) within a 1 hour period.
- a high signal-to-noise ratio is essential for the successful application of a rapid separation and concentration technique particularly in primary food enrichment broths. Therefore, this system may be used in combination with the Microcellector flasks described above to produce a simple, robust and rapid system for the isolation of Salmonella.
- coli 0157 was significant, as indicated by the high level of depletion (range 70-90%), with a corresponding reduction in the non-specific binding of competing organisms (indicated by a lower depletion ranging from 0-40%) from both pure and mixed cultures.
- the technique was shown to be highly sensitive as the separation procedure was carried out during concomitant growth of bacterial cells (starting level approximately 10 cfu/ml) in the pre-enrichment broth.
- kits for carrying out the method of the invention form a further aspect of invention.
- the kits may comprise an element which provides a suitable surface, such as a nitrocellulose membrane or a Microcellector flask, and a suitable binding member or range of binding members for various microorganisms which are to be detected. These binding member(s) may be fixed to the surface, or may be supplied separately with instructions for their administration.
- Other reagents which may be included in the kits include detection reagents such as labelled antibodies, diagnostic growth media or the like.
- the kit will include growth media in which the target microorganisms will multiply, suitably growth media which favours the growth of the target microorganism.
- the method in accordance with the invention may be used to detect a range of microorganisms including bacteria (both gram positive and gram negative bacteria), bacterial spores, yeasts, moulds, fungal spores, viruses, protozoan cells such as Cryptosporidium, and oocysts. It is particularly useful in the detection of organisms which cause diseases.
- pathogenic bacteria such as Salmonella, Lister ia, Campylobacter, pathogenic strains of E. coli such as VTEC, and Staphylococcus aureus may be detected.
- the method may be applicable in a wide range of industrial applications, for example, in the food and beverage industries, water, agriculture, medicare and pharmaceutical industries as well as in public health monitoring.
- the invention will now be particularly described by way of example with reference to the accompanying diagrammatic drawings in which:
- Figure 1 shows flasks which have contained Salmonella samples, one of which is antibody sensitised to Salmonella and the other which has not;
- Figure 2 shows the binding of S. enteritidis from a mixed culture containing E. coli on to cellulose membranes treated with and without antibody to Salmonella
- Figure 3 shows the binding of S. enteritidis from a mixed culture(top), and of £. coli from a pure culture (bottom) on to cellulose membranes treated with antibody to Salmonella.
- a commercially available polyclonal antibody against Salmonella was immobilised directly or indirectly (via a Protein G linker) onto the Microcellector flask.
- the coated flask was used to specifically separate and concentrate Salmonella from pure and mixed cultures.
- Cell depletion was monitored by sampling the nonadherent cell population in suspension and plating on to appropriate microbiological media.
- the bound cell population was detected by adding a thin layer of a diagnostic agar to the flask and monitoring the characteristic colony appearance.
- Table 1 shows the extent of depletion of pure cultures of S enteritidis RI and E coli R6 in Microcellector flasks coated with polyclonal antibody to Salmonella
- Table II shows the results of the repeat expenment using Microcellector flask directly coated with the polyclonal antibody to Salmonella The control vials did not contain the antibody TABLE II
- Table III shows results of further experiments using pure and mixed cultures containing S. enteritidis and E. coli, and Microcellector flasks directly coated with the polyclonal antibody to Salmonella.
- cellulose membrane-based separation technique for Salmonella The following cellulose membrane-based separation technique was developed with a view to enhancing specific separation of pathogens using uncoated Microcellector flasks, or indeed any other flask.
- the technique involved the use of a recombinant protein for the immobilisation of antibodies on the surface of a cellulose membrane.
- the membrane was ⁇ gorously washed with 6 x 10ml portions of PBS, and the moist membrane transferred to the surface of a diagnostic agar (XLD) plate The plate was incubated at 37°C for 24 hours and the bactenal growth and colony appearance monitored
- Figure 2 shows the specific binding of Salmonella (black colonies) from a mixed culture (S enteritidis and E coli at approximately 10 5 cfu/ml) using a cellulose membrane coated with antibody to Salmonella
- Figure 2 shows a low degree of non-specific binding (black and yellow colonies Salmonella and E coli respectively) from the same mixed culture using a cellulose membrane that was not treated with antibody
- Figure 3 shows the specific binding of Salmonella (black colonies) from a mixed culture (S enteritidis and E coli at approximately 10 5 cfu/ml), and the extent of non-specific binding of E coli (pure culture at approximately 10 5 cfu/ml), using anti-Salmonella antibody- coated cellulose membranes From the mixed culture, there was significant binding and subsequent growth of Salmonella, with no visual observation of any growth of £ coli The non- specific binding of £ coli from the pure culture was patchy, mainly around the outer edge of the membrane The agar medium colour changed from red to yellow due to acid production by E coli
- Example 2 A modified technique to that described in Example 2, which allows scale-up of the procedure for use with larger sample volumes was effected as follows.
- Cellulose binding domain-Protein A solution (4 ml of lOO ⁇ g/ml, Sigma) were added to an uncoated tissue culture flask containing a cellulose membrane insert (Spectra/Por 3, MWCO 3500, Spectrum) and incubated at ambient temperature for 1 hour.
- the membrane was washed with 3 x 10 ml portions of PBS prior to the addition of rabbit anti-Salmonella polyclonal antibody (4ml, 1:200 dilution, Biogenesis).
- the flask was incubated at ambient temperature for 1 hour, washed with 3 x 10ml portions of PBS, and the remaining binding sites blocked with 10 ml of 0.5% casein solution.
- the flask was incubated at ambient temperature for 1 hour and then washed with 3 x 10ml portions of PBS.
- Cell separation was assessed by adding either 5 ml or 25ml of a bacterial cell suspension in various media at approximately lOcfu/ml and 10 or 10 5 cfu/ml for target cells and competing cells, respectively.
- the inoculated flask was incubated at 37°C for 6 hours with gentle mixing (incubator shaker, new Brunswick Scientific), Controls were set up in non-treated glass vials (i.e. without the antibody sensitised membrane) in order to monitor the levels of cells in the test samples over the separation period. After 6 hours, the flask was agitated in order to resuspend the non-adhered cells and a portion (lOO ⁇ l) was removed for enumeration on selective diagnostic agar (XLD). The plate was incubated at 37°C for 24 hours and the resulting colonies counted. The extent of depletion was then calculated.
- Table V compares the extent of depletion of S. enteritidis RI and E. coli R6 from static cultures (5ml starting level of approximately 10 5 cfu/ml in sterile distilled water) and during concomitant growth (also 5ml starting level of approximately 10 cfu/ml in TSB) .
- Table VI shows the separation of 5 enteritidis RI and £ coli R6 during concomitant growth over 6 hours using 5 and 25 ml volumes of TSB inoculated with the starting level of approximately 10 cfu/ml bacteria
- Tables VII and VIII show the separation of Salmonella dunng concomitant growth of pure and mixed cultures, respectively in 25 ml buffered peptone water (BPW) and the level of nonspecific separation of a range of competing organisms
- the flasks contained membrane sensitised with antibody to Salmonella Table VII Separation of S Enteritidis RI, S. typhimurium R5, £ coli R6, C.freundii G2 and L monocytogenes B2 dunng concomitant growth of pure cultures in BPW
- Example 4 The method of Example 4 was repeated using vanous cultures of £ coli
- the membranes introduced into the flask in this instance had been sensitised in a similar manner but using an antibody to E coli 0157
- Table IX shows the separation of £ coli 0157 R121 and £ coli R6 dunng concomitant growth over 6 hours using 5 and 25 ml volumes of TSB inoculated with approximately 10 cfu/ml bacteria TABLE IX
- Tables X and XI show the separation of £. coli 0157 during concomitant growth of pure and mixed cultures, respectively, in 25ml BPW and the level of non-specific separation of a range of competing organisms.
- the preliminary results for the ELISA showed a degree of specificity for Salmonella, as compared with the non-specific detection of Listeria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU43134/97A AU4313497A (en) | 1996-09-28 | 1997-09-23 | Microorganism separation system |
GB9907256A GB2333105A (en) | 1996-09-28 | 1997-09-23 | Microorganism separation system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9620279.1 | 1996-09-28 | ||
GBGB9620279.1A GB9620279D0 (en) | 1996-09-28 | 1996-09-28 | Microorganism separation system |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998013692A1 true WO1998013692A1 (en) | 1998-04-02 |
Family
ID=10800657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1997/002583 WO1998013692A1 (en) | 1996-09-28 | 1997-09-23 | Microorganism separation system |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4313497A (en) |
GB (1) | GB9620279D0 (en) |
WO (1) | WO1998013692A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5013664A (en) * | 1986-05-28 | 1991-05-07 | Brodeur Bernard R | Common protein of Haemophilus influenzae type b identified by a monoclonal antibody |
US5116724A (en) * | 1984-10-04 | 1992-05-26 | Immunotech | Products for separation applicable to cells in the immunopurification field |
WO1993019372A1 (en) * | 1992-03-25 | 1993-09-30 | Safefood Micro-System A/S | Method of detecting microorganisms |
US5322788A (en) * | 1992-04-09 | 1994-06-21 | Global Tek, Inc. | Monoclonal anti-body to cell surface protein of the bacterium Streptococcus pneumoniae |
-
1996
- 1996-09-28 GB GBGB9620279.1A patent/GB9620279D0/en active Pending
-
1997
- 1997-09-23 AU AU43134/97A patent/AU4313497A/en not_active Abandoned
- 1997-09-23 WO PCT/GB1997/002583 patent/WO1998013692A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5116724A (en) * | 1984-10-04 | 1992-05-26 | Immunotech | Products for separation applicable to cells in the immunopurification field |
US5013664A (en) * | 1986-05-28 | 1991-05-07 | Brodeur Bernard R | Common protein of Haemophilus influenzae type b identified by a monoclonal antibody |
WO1993019372A1 (en) * | 1992-03-25 | 1993-09-30 | Safefood Micro-System A/S | Method of detecting microorganisms |
US5322788A (en) * | 1992-04-09 | 1994-06-21 | Global Tek, Inc. | Monoclonal anti-body to cell surface protein of the bacterium Streptococcus pneumoniae |
Also Published As
Publication number | Publication date |
---|---|
GB9620279D0 (en) | 1996-11-13 |
AU4313497A (en) | 1998-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2112603C (en) | Assay method for detecting the presence of bacteria | |
US11092600B2 (en) | Method for the real-time detection of microorganisms in a liquid culture medium by agglutination | |
US7642060B2 (en) | Rapid resuscitation, growth, capture and detection of microorganisms | |
US7491488B2 (en) | Methods, compositions, and kits for the detection of bacteria in a sample | |
Vermunt et al. | Isolation of salmonellas by immunomagnetic separation | |
US20090269788A1 (en) | Method for detecting microorganism | |
CA2328249A1 (en) | Real time detection of antigens | |
NZ251677A (en) | Method of immunologically detecting viable microorganisms by detection of an indicator epitope present only on the surface of viable microorganisms | |
US4617264A (en) | Pretreatment method and composition | |
US7241626B2 (en) | Isolation and confirmation of analytes from test devices | |
JP3773633B2 (en) | Analysis method and reagent for E. coli O157 | |
US20150079597A1 (en) | Method for capturing and concentrating a microorganism in a biological sample | |
Desai et al. | Solid-phase capture of pathogenic bacteria by using gangliosides and detection with real-time PCR | |
WO1998013692A1 (en) | Microorganism separation system | |
US9169508B2 (en) | Method for real-time detection of microorganisms in a liquid culture medium using cellular lysis | |
JPWO2002065131A1 (en) | Methods and reagents for detecting Vibrio bacteria and antibodies used therefor | |
RU2611359C1 (en) | Method and set for determination of cholera toxin production and differentiation of epidemiologically significant strains of cholera vibrios of classical and el tor biovars | |
JP2001004631A (en) | Rapid assay for microbe using magnetic bead immobilized antibody | |
JP2004154075A (en) | New analyzing method | |
JP2023538876A (en) | Method for isolating and/or detecting and/or in vitro quantifying infectious compounds in biological materials | |
NO173714B (en) | PROCEDURE FOR QUALITATIVE AND QUANTITATIVE DETERMINATION OF SPECIAL ANTIGENS, SPECIAL TRACKS OF CLOSTRIDIUM TYROBUTYRICUM |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 1998515383 Format of ref document f/p: F |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |